Sarepta Therapeutics | 영업 이익





영업 이익 변화 날짜
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.39B 1.37B 2025-09
Gilead Sciences USD 3.51B 810M 2025-09
Incyte USD 431.31M 120.49M 2025-09
Insmed USD -261.35M 7.48M 2025-09
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
Moderna USD -260M 647M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Tectonic Therapeutic USD -21.89M 440K 2025-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Sarepta Therapeutics 영업 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.